Gilead Sciences (GILD) call put ratio 2.3 calls to 1 put after FT says remdesivir failed in first trial
Go back to Gilead Sciences (GILD) call put ratio 2.3 calls to 1 put after FT says remdesivir failed in first trial| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.28 +0.41 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.87 | 52 Week High | $108.63 | |||
| Open | $126.63 | 52 Week Low | $71.39 | |||
| Day High | $126.63 | P/E | 69.22 | |||
| Day Low | $124.44 | EPS | $1.81 | |||
| Volume | 4,351,459 | |||||
